Enzalutamide – Active Substance

Enzalutamide is an active substance classified as an anti-androgen used in the treatment of prostate cancer. It is utilized for the management of metastatic and non-metastatic castration-resistant prostate cancer by blocking the action of androgens (male hormones) that stimulate the growth of cancer cells. Enzalutamide binds to androgen receptors and inhibits their activation, slowing disease progression and reducing the risk of complications. The use of enzalutamide contributes to prolonged survival, improved quality of life, and better symptom control in patients with prostate cancer. The substance is often prescribed as part of combination therapy and is included in modern international treatment protocols for oncology patients.